Benjamin Kopp, MD/MPH (@KidsLungDoc) header
Benjamin Kopp, MD/MPH (@KidsLungDoc) profile picture

Benjamin Kopp, MD/MPH

@KidsLungDoc

Christian, Pediatric Cystic Fibrosis and Sickle Cell Lung Disease, Researcher, Father, husband, & lover of all Buckeyes! @EmoryUniversity, Co-Director CF-AIR

 Emory University
Joined January 2014
  • Tweets3K
  • Following1.3K
  • Followers1.6K
If you are an expert, it's your responsibility to be an advocate. i consider all parents the prime expert/advocate for their kids!
6
30
3
46
Happening in 1 month - Pediatric Early Career Researcher Conference, featuring a keynote presentation from Dr. @stephenwpatrick. Seating availability is limited so reserve your spot today! ✅ Register (free): bit.ly/2025ECR ➡️ Learn more: bit.ly/3EmwPEz
Image from Pediatric Research Alliance (@AtlPedsResearch)
2
4
275
Research Article by J Moran et al. (@KidsLungDoc @emoryuniversity @nationwidekids @YaleMed) #ENaC contributes to #macrophage dysfunction in #cysticfibrosis | #phagocyte #ionchannels #CFTR ow.ly/agV550WeNLq
Image from AJP-Lung Cellular and Molecular Physiology (@AJPLung)
2
3
186
JCI Insight - Annual PM2.5 exposure and clinical, laboratory, and stroke-risk outcomes in pediatric sickle cell disease insight.jci.org/articles/vie…
1
7
158
Research Article by BL Wisniewski et al. (@CUAnschutz @EmoryMedicine @OhioState @KidsLungDoc @EstelleBoyaka) Secondhand vape exposure regulation of CFTR and immune function in cystic fibrosis #vaping #cysticfibrosis #CFTR #inflammation 🔒ow.ly/HvMQ50V64UT
Image from AJP-Lung Cellular and Molecular Physiology (@AJPLung)
1
4
242
frontiersin.org/journals/imm…
Frontiers | Proteomics profiling of inflammatory responses to elexacaftor/tezacaftor/ivacaftor in...

Frontiers | Proteomics profiling of inflammatory responses to elexacaftor/tezacaftor/ivacaftor in...

BackgroundCFTR modulator therapies have positive clinical outcomes, yet chronic inflammation and bacterial infections persist in people with CF (pwCF). How e...

frontiersin.org
104
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis ag… pubmed.ncbi.nlm.nih.gov/3975…
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with...

Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with...

Vertex Pharmaceuticals.

pubmed.ncbi.nlm.nih.gov
2
4
228
Congrats to Rabin Tirouvanziam for being awarded the Raymond Schinazi distinguished biomedical chair! @CFAtlanta @EmoryCHOA_CFAIR @EmoryPediatrics
Image from Benjamin Kopp, MD/MPH (@KidsLungDoc)
13
2
4
644
Benjamin Kopp, MD/MPH retweeted
CF-AIR (@EmoryCHOA_CFAIR) profile picture
CF-AIR@EmoryCHOA_CFAIR1 Nov 2024
Excited that our team received @CF_Foundation 's 2024 Outstanding Care Center Partnership Award at #nacfc, recognizing care centers going above & beyond in collaborating with local CF Foundation chapters 👏@EmoryPediatrics @childrensatl @KidsLungDoc @naelmccarty @AtlPedsResearch
Image from CF-AIR (@EmoryCHOA_CFAIR)
4
3
2
4
1,349
Voted!
Image from Benjamin Kopp, MD/MPH (@KidsLungDoc)
9
165
Thank you to Dr. Benjamin Kopp (@KidsLungDoc ) for an incredible seminar yesterday, "Modulating Chronic Lung Diseases: Insights Into Cystic Fibrosis." @EmoryMedicine Thank you to everyone who attended! #UGAVETMED
Image from Department of Infectious Diseases, UGA (@UGA_IDIS)
1
3
6
311
Great work Sriram and team! DNA-PKcs inhibition improves sequential gene insertion of the full-length CFTR cDNA in airway stem cells pubmed.ncbi.nlm.nih.gov/3939…
DNA-PKcs inhibition improves sequential gene insertion of the full-length CFTR cDNA in airway stem...

DNA-PKcs inhibition improves sequential gene insertion of the full-length CFTR cDNA in airway stem...

Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Although many people with CF (pwCF) are treated using CFTR modulators, some are...

pubmed.ncbi.nlm.nih.gov
1
2
3
207
Congrats Bum-Yong on your new work! @EmoryCHOA_CFAIR @EmoryPediatrics PPARγ/ETV2 axis regulates endothelial‐to‐mesenchymal transition in pulmonary hypertension onlinelibrary.wiley.com/doi/…
PPARγ/ETV2 axis regulates endothelial‐to‐mesenchymal transition in pulmonary hypertension

PPARγ/ETV2 axis regulates endothelial‐to‐mesenchymal transition in pulmonary hypertension

Endothelial-to-mesenchymal transition (EndoMT) plays an important role in pulmonary hypertension (PH) but the molecular mechanisms regulating EndoMT remain to be defined. We demonstrate that the...

onlinelibrary.wiley.com
3
1
3
216
Nice work from McCarty lab! @EmoryCHOA_CFAIR Development of a programmable automated cell culture system to study the lung pathophysiology of Cystic Fibrosis-related diabetes: Heliyon cell.com/heliyon/fulltext/S2…

Development of a programmable automated cell culture system to study the lung pathophysiology of...

The study of many diseases is limited by the in vitro systems available. Cystic Fibrosis-Related Diabetes (CFRD), the main co-morbidity of Cystic Fibrosis (CF), is a perfect example. Cells in vivo...

cell.com
1
6
273
Benjamin Kopp, MD/MPH retweeted
ASCENT Network (@ASCENT_USA) profile picture
ASCENT Network@ASCENT_USA3 Oct 2024
Update from @ASCENT_USA Atlanta South Dekalb measurement station by  @SallyNgGroup: A spike in chlorine-containing particles (200x higher than typical) and bromine-containing particles (15x higher than typical) at 12pm; both decreased afterwards.
Image from ASCENT Network (@ASCENT_USA)
Image from ASCENT Network (@ASCENT_USA)
2
6
7
841
Post-doc star Hazel Ozuna ⁦@hazelota⁩ led a fabulous session on immunometabolism at #NACFC2024!⁦@EmoryCHOA_CFAIR⁩ ⁦@childrensatl⁩ ⁦@EmoryPediatrics⁩
Image from Benjamin Kopp, MD/MPH (@KidsLungDoc)
1
14
262
Kudos to this fabulous team presenting fabulous, equity driving work to improve cf newborn screening! ⁦@EmoryCHOA_CFAIR⁩ ⁦@EmoryPediatrics⁩ ⁦@childrensatl⁩
Image from Benjamin Kopp, MD/MPH (@KidsLungDoc)
1
1
12
311
Benjamin Kopp, MD/MPH retweeted
CF-AIR (@EmoryCHOA_CFAIR) profile picture
CF-AIR@EmoryCHOA_CFAIR28 Sep 2024
Final day in Boston @CF_Foundation's #nacfc! Some snapshots: Sam Durfey, PhD presenting her research and our team collaborating with researchers from around the world 🌎 @EmoryCHOA_CFAIR @CFAtlanta @AtlPedsResearch @childrensatl @EmoryPediatrics @KidsLungDoc @naelmccarty
Image from CF-AIR (@EmoryCHOA_CFAIR)
Image from CF-AIR (@EmoryCHOA_CFAIR)
1
4
126
Benjamin Kopp, MD/MPH retweeted
CF-AIR (@EmoryCHOA_CFAIR) profile picture
CF-AIR@EmoryCHOA_CFAIR27 Sep 2024
Update from Boston! Our Children's, Emory and affiliates @EmoryCHOA_CFAIR @CFAtlanta are gathered after the first two days of learning and collaborating 💡at the @CF_Foundation's #nacfc. @AtlPedsResearch @childrensatl @EmoryPediatrics @EmoryPostdocs @naelmccarty @KidsLungDoc
Image from CF-AIR (@EmoryCHOA_CFAIR)
1
3
152
More exciting news today! ASH Priorities for #SickleCell Disease and Sickle Cell Trait - Hematology.org Great to see more comprehensive topics- but still missing transitional care for end-organ disease like the #Lung! ⁦@ASH_hematology⁩ hematology.org/research/sick…
3
110
Just in time for #NACFC2024! Cystic fibrosis foundation position paper: Redefining the CF care model - Journal of Cystic Fibrosis cysticfibrosisjournal.com/ar…

Cystic fibrosis foundation position paper: Redefining the CF care model

The hallmark of cystic fibrosis (CF) care is the interdisciplinary team approach in providing both surveillance for the development of disease progression and acute care of complications. Pioneered...

cysticfibrosisjournal.com
2
1
6
754
Load more